↓ Skip to main content

Chemotherapy for children with medulloblastoma

Overview of attention for article published in Cochrane database of systematic reviews, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
14 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
120 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy for children with medulloblastoma
Published in
Cochrane database of systematic reviews, January 2015
DOI 10.1002/14651858.cd006678.pub2
Pubmed ID
Authors

Erna MC Michiels, Antoinette YN Schouten-Van Meeteren, François Doz, Geert O Janssens, Elvira C van Dalen

Abstract

Post-surgical radiotherapy (RT) in combination with chemotherapy is considered as standard of care for medulloblastoma in children. Chemotherapy has been introduced to improve survival and to reduce RT-induced adverse effects. Reduction of RT-induced adverse effects was achieved by deleting (craniospinal) RT in very young children and by diminishing the dose and field to the craniospinal axis and reducing the boost volume to the tumour bed in older children.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Brazil 1 <1%
Unknown 118 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 23%
Researcher 21 18%
Student > Master 20 17%
Student > Ph. D. Student 11 9%
Other 6 5%
Other 17 14%
Unknown 17 14%
Readers by discipline Count As %
Medicine and Dentistry 56 47%
Neuroscience 8 7%
Agricultural and Biological Sciences 6 5%
Nursing and Health Professions 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 17 14%
Unknown 23 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2015.
All research outputs
#1,557,261
of 14,255,789 outputs
Outputs from Cochrane database of systematic reviews
#4,183
of 10,921 outputs
Outputs of similar age
#35,237
of 297,721 outputs
Outputs of similar age from Cochrane database of systematic reviews
#116
of 247 outputs
Altmetric has tracked 14,255,789 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,921 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.7. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,721 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 247 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.